ELYSSA FOSTER: Open Payments
NPI 1528776531 · BEND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,215 in 73 payments from 16 companies in 2025. Trend: 2023 $2,154 · 2024 $4,525 · 2025 $7,215
Honoraria: $3,200Food & beverage: $2,636Travel & lodging: $1,276Education: $100Speaker / faculty: $3
| Company | Payments | Amount |
|---|---|---|
| ADC THERAPEUTICS AMERICA, INC. | 19 | $5,009 |
| Janssen Biotech, Inc. | 11 | $524 |
| Adaptive Biotechnologies Corporation | 6 | $497 |
| Daiichi Sankyo Inc. | 21 | $388 |
| Janssen Scientific Affairs, LLC | 2 | $186 |
| Syndax Pharmaceuticals, Inc. | 1 | $145 |
| Kite Pharma, Inc. | 1 | $126 |
| Astellas Pharma US Inc | 3 | $90 |
| Legend Biotech USA Inc. | 1 | $85 |
| Bard Peripheral Vascular, Inc. | 1 | $31 |
Products named: ZYNLONTA, clonoSEQ, Vanflyta, CARVYKTI, RYBREVANT, REVUFORJ, Yescarta, DARZALEX.
Industry payments across OR — which companies pay providers there.
